BlueLinx Holdings Inc. | BlueLinx Holdings | wholesalers | investor protection violation | 2016 | $265,000 |
Cardinal Health, Inc. | Cardinal Health | wholesalers | accounting fraud or deficiencies | 2007 | $35,000,000 |
Cardinal Health, Inc. | Cardinal Health | wholesalers | Foreign Corrupt Practices Act | 2020 | $8,000,000 |
Stericycle, Inc. | Stericycle | waste management and environmental services | Foreign Corrupt Practices Act | 2022 | $28,200,000 |
ABB Ltd. | ABB Ltd. | utilities and power generation | Foreign Corrupt Practices Act | 2010 | $39,300,000 |
Broadwind Energy | Broadwind Inc. | utilities and power generation | accounting fraud or deficiencies | 2015 | $1,000,000 |
Nicor, Inc. | Southern Company | utilities and power generation | accounting fraud or deficiencies | 2007 | $10,000,000 |
ABB Ltd | ABB Ltd. | utilities and power generation | Foreign Corrupt Practices Act | 2004 | $5,900,000 |
Dynegy Inc. | Vistra Energy | utilities and power generation | accounting fraud or deficiencies | 2002 | $3,000,000 |
SCANA Corp. | Dominion Energy | utilities and power generation | investor protection violation | 2020 | $137,500,000 |
ABB Ltd | ABB Ltd. | utilities and power generation | Foreign Corrupt Practices Act | 2022 | $75,000,000 |
Plug Power Inc. | Plug Power Inc. | utilities and power generation | investor protection violation | 2023 | $1,250,000 |
Exelon Corporation | Exelon | utilities and power generation | fraud | 2023 | $46,200,000 |
Universal Corporation Inc. | Universal Corporation | tobacco | Foreign Corrupt Practices Act | 2010 | $4,500,000 |
Alliance One International Inc. | Pyxus International | tobacco | Foreign Corrupt Practices Act | 2010 | $10,000,000 |
VimpelCom Ltd. | VEON | telecommunications | Foreign Corrupt Practices Act | 2016 | $167,500,000 |
Magyar Telekom Plc | Deutsche Telekom | telecommunications | Foreign Corrupt Practices Act | 2011 | $31,200,000 |
Alcatel-Lucent S.A. | Nokia | telecommunications | Foreign Corrupt Practices Act | 2010 | $45,000,000 |
Lucent Technologies Inc. | Nokia | telecommunications | Foreign Corrupt Practices Act | 2007 | $1,500,000 |
Motorola Inc. | Motorola Solutions | telecommunications | accounting fraud or deficiencies | 2007 | $25,000,000 |
Qwest Communications International Inc. | Lumen Technologies | telecommunications | accounting fraud or deficiencies | 2004 | $250,000,000 |
Lucent Technologies Inc. | Nokia | telecommunications | accounting fraud or deficiencies | 2004 | $25,000,000 |
Vivendi Universal, S.A. | Comcast | telecommunications | accounting fraud or deficiencies | 2003 | $50,000,000 |
WorldCom Inc. | Verizon Communications | telecommunications | accounting fraud or deficiencies | 2003 | $500,000,000 |
BellSouth Corporation | AT&T | telecommunications | Foreign Corrupt Practices Act | 2002 | $150,000 |
Telia Company AB | Telia Company AB | telecommunications | Foreign Corrupt Practices Act | 2017 | $457,000,000 |
Ribbon Communications Inc. (fka Sonus Networks) | Ribbon Communications | telecommunications | investor protection violation | 2018 | $1,900,000 |
Mobile TeleSystems PJSC | Mobile TeleSystems PJSC | telecommunications | Foreign Corrupt Practices Act | 2019 | $100,000,000 |
Ericsson | Ericsson | telecommunications | Foreign Corrupt Practices Act | 2019 | $539,000,000 |
AT&T | AT&T | telecommunications | investor protection violation | 2022 | $6,250,000 |
Charter Communications Inc. | Charter Communications | telecommunications | accounting fraud or deficiencies | 2023 | $25,000,000 |
Cabela's | Bass Pro | retailing | accounting fraud or deficiencies | 2016 | $1,000,000 |
CVS Caremark Corp. | CVS Health | retailing | accounting fraud or deficiencies | 2014 | $20,000,000 |
Office Depot, Inc. | ODP Corporation | retailing | investor protection violation | 2010 | $1,000,000 |
Dollar General Corporation | Dollar General | retailing | accounting fraud or deficiencies | 2005 | $10,000,000 |
Walgreens Boots Alliance Inc. | Walgreens Boots Alliance | retailing | investor protection violation | 2018 | $34,500,000 |
Walmart | Walmart | retailing | Foreign Corrupt Practices Act | 2019 | $144,000,000 |
The Cheesecake Factory Incorporated | Cheesecake Factory | restaurants and foodservice | accounting fraud or deficiencies | 2020 | $125,000 |
St. Joe Company | St. Joe Company | real estate | accounting fraud or deficiencies | 2015 | $2,750,000 |
W.P. Carey & Co. | W.P. Carey Inc. | real estate | accounting fraud or deficiencies | 2008 | $30,000,000 |
Jones Lang LaSalle Incorporated | Jones Lang LaSalle | real estate | investor protection violation | 2014 | $150,000 |
Vereit, Inc. | Realty Income | real estate | investor protection violation | 2020 | $8,000,000 |
CBRE, Inc. | CBRE Group | real estate | investor protection violation | 2023 | $375,000 |
Blackstone Group | Blackstone | private equity (including portfolio companies) | investor protection violation | 2015 | $39,000,000 |
Kohlberg Kravis Roberts & Co. | KKR & Co. | private equity (including portfolio companies) | investor protection violation | 2015 | $30,000,000 |
Analogic Corp. | Altaris Capital Partners | private equity (including portfolio companies) | Foreign Corrupt Practices Act | 2016 | $11,470,000 |
Royal Alliance Associates, SagePoint Financial and FSC Securities Corporation | Reverence Capital Partners | private equity (including portfolio companies) | investor protection violation | 2016 | $9,500,000 |
JDA Software Group Inc. | New Mountain Capital | private equity (including portfolio companies) | accounting fraud or deficiencies | 2014 | $750,000 |
Apollo Global Management | Apollo Global Management | private equity (including portfolio companies) | investor protection violation | 2016 | $52,700,000 |
VeriFone Holdings, Inc. | Francisco Partners | private equity (including portfolio companies) | accounting fraud or deficiencies | 2009 | $25,000 |
Akzo Nobel N.V. | Carlyle Group | private equity (including portfolio companies) | Foreign Corrupt Practices Act | 2007 | $2,981,513 |
McAfee, Inc. | Advent International | private equity (including portfolio companies) | accounting fraud or deficiencies | 2006 | $50,000,000 |
TPG Capital | TPG Capital | private equity (including portfolio companies) | investor protection violation | 2001 | $50,000 |
America Online, Inc. | Apollo Global Management | private equity (including portfolio companies) | accounting fraud or deficiencies | 2000 | $3,500,000 |
TPG Capital Advisors, LLC | TPG Capital | private equity (including portfolio companies) | investor protection violation | 2017 | $12,487,620 |
Platinum Equity Advisors, LLC | Platinum Equity | private equity (including portfolio companies) | investor protection violation | 2017 | $3,402,132 |
KMS Financial Services, Inc. | Reverence Capital Partners | private equity (including portfolio companies) | investor protection violation | 2017 | $552,086 |
Ladenburg Thalmann Asset Management Inc. | Reverence Capital Partners | private equity (including portfolio companies) | investor protection violation | 2016 | $200,000 |
Securities America Advisors Inc. | Reverence Capital Partners | private equity (including portfolio companies) | investor protection violation | 2018 | $5,828,448 |
Institutional Shareholder Services Inc. | Genstar Capital | private equity (including portfolio companies) | investor protection violation | 2013 | $300,000 |
EnCap Investments L.P. | Encap Investments | private equity (including portfolio companies) | investor protection violation | 2018 | $500,000 |
Ingram Micro Inc. | Platinum Equity | private equity (including portfolio companies) | investor protection violation | 2009 | $15,000,000 |
Royal Alliance Associates, Inc. | Reverence Capital Partners | private equity (including portfolio companies) | investor protection violation | 2009 | $500,001 |
Woodbury Financial Services, Inc. | Reverence Capital Partners | private equity (including portfolio companies) | investor protection violation | 2009 | $65,000 |
Woodbury Financial Services, Inc. | Reverence Capital Partners | private equity (including portfolio companies) | investor protection violation | 2019 | $1,171,028 |
ADT Inc. | Apollo Global Management | private equity (including portfolio companies) | investor protection violation | 2018 | $100,000 |
Ares Management LLC | Ares Management | private equity (including portfolio companies) | investor protection violation | 2020 | $1,000,000 |
Monomoy Capital Management, L.P. | Monomoy Capital Partners | private equity (including portfolio companies) | investor protection violation | 2020 | $1,926,579 |
AmTrust Financial Services Inc. | Stone Point Capital | private equity (including portfolio companies) | investor protection violation | 2020 | $10,300,000 |
Royal Alliance Associates, Inc. | Reverence Capital Partners | private equity (including portfolio companies) | investor protection violation | 2020 | $502,400 |
Securities America Advisors, Inc. | Reverence Capital Partners | private equity (including portfolio companies) | investor protection violation | 2020 | $603,776 |
KMS Financial Services Inc. | Reverence Capital Partners | private equity (including portfolio companies) | investor protection violation | 2021 | $200,000 |
KMS Financial Services, Inc. | Reverence Capital Partners | private equity (including portfolio companies) | investor protection violation | 2021 | $200,000 |
Securities America Advisors, Inc. | Reverence Capital Partners | private equity (including portfolio companies) | investor protection violation | 2021 | $1,750,000 |
Energy Capital Partners Management LP | Energy Capital Partners | private equity (including portfolio companies) | investor protection violation | 2022 | $1,000,000 |
Woodbury Financial Services, Inc. | Reverence Capital Partners | private equity (including portfolio companies) | investor protection violation | 2023 | $100,000 |
SagePoint Financial, Inc. | Reverence Capital Partners | private equity (including portfolio companies) | investor protection violation | 2023 | $100,000 |
El Paso Corporation | Kinder Morgan | pipelines | Foreign Corrupt Practices Act | 2007 | $7,700,000 |
Novartis AG | Novartis | pharmaceuticals | Foreign Corrupt Practices Act | 2016 | $25,000,000 |
SciClone Pharmaceuticals | SciClone Pharmaceuticals | pharmaceuticals | Foreign Corrupt Practices Act | 2016 | $12,000,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | pharmaceuticals | Foreign Corrupt Practices Act | 2015 | $14,000,000 |
Eli Lilly and Company | Eli Lilly | pharmaceuticals | Foreign Corrupt Practices Act | 2012 | $29,398,734 |
Pfizer Inc. | Pfizer | pharmaceuticals | Foreign Corrupt Practices Act | 2012 | $26,339,944 |
Wyeth LLC | Pfizer | pharmaceuticals | Foreign Corrupt Practices Act | 2012 | $18,876,624 |
Johnson & Johnson | Johnson & Johnson | pharmaceuticals | Foreign Corrupt Practices Act | 2011 | $48,600,000 |
Novo Nordisk A/S | Novo Holdings A/S | pharmaceuticals | Foreign Corrupt Practices Act | 2009 | $9,030,149 |
Biovail Corporation | Bausch Health | pharmaceuticals | accounting fraud or deficiencies | 2008 | $10,000,000 |
Elan Corporation, plc | Perrigo | pharmaceuticals | accounting fraud or deficiencies | 2005 | $15,000,000 |
Bristol-Myers Squibb Company | Bristol-Myers Squibb | pharmaceuticals | accounting fraud or deficiencies | 2004 | $150,000,000 |
Schering-Plough Corporation | Merck | pharmaceuticals | Foreign Corrupt Practices Act | 2004 | $500,000 |
Schering-Plough Corporation | Merck | pharmaceuticals | investor protection violation | 2003 | $1,000,000 |
ICN Pharmaceuticals, Inc. | Bausch Health | pharmaceuticals | accounting fraud or deficiencies | 2002 | $1,000,000 |
AstraZeneca PLC | AstraZeneca | pharmaceuticals | kickbacks and bribery | 2016 | $5,522,000 |
GlaxoSmithKline plc | GlaxoSmithKline | pharmaceuticals | kickbacks and bribery | 2016 | $20,000,000 |
Teva Pharmaceutical Industries Limited | Teva Pharmaceutical Industries | pharmaceuticals | Foreign Corrupt Practices Act | 2016 | $236,000,000 |
Allergan Inc. | AbbVie | pharmaceuticals | investor protection violation | 2017 | $15,000,000 |
Galena Biopharma, Inc. | SELLAS Life Sciences Group | pharmaceuticals | accounting fraud or deficiencies | 2017 | $200,000 |
Alere Inc. | Abbott Laboratories | pharmaceuticals | accounting fraud or deficiencies | 2017 | $13,023,885 |
Aegerion Pharmaceuticals | Amryt Pharma | pharmaceuticals | investor protection violation | 2017 | $4,100,000 |
Cytrx Corporation | CytRx | pharmaceuticals | investor protection violation | 2017 | $75,000 |
Sanofi | Sanofi | pharmaceuticals | Foreign Corrupt Practices Act | 2018 | $25,200,000 |